Soy phosphatidylserine approved for cognitive health claims in Australia and New Zealand

January 16, 2020

In Australia and New Zealand, products with soy phosphatidylserine can now make the claim that the product supports the "Maintenance and/or improvement of cognitive function and brain heatlh."

Following the notification of a self-substantiated food-health relationship, the Food Standards Australia New Zealand (FSANZ) authority has accepted and listed a claim for soy phosphatidylserine from the branded ingredient Sharp-PS (from IFF Health; New York City, NY) for the “Maintenance and/or improvement of cognitive function and brain health.” This new claim allows Australian and New Zealand brands the option to add Sharp-PS to their products, and opens up the opportunity to launch function food products that target cognitive health. 

“The ability to include brain health and cognitive claims with Sharp-PS is exciting and creates a unique opportunity for IFF and for better-for-you food and beverage makers in Australia and New Zealand,” said Pinni Raveh, sales manager for IFF Health, in a press release.

“The benefits of PS consumption have been demonstrated in numerous clinical and pre-clinical studies, leading FSANZ to link its consumption to these benefits,” added Itay Shafat, PhD, product manager for Cognitive Line, IFF Health, in a press release. “Phosphatidylserine is ideal for inclusion into food and beverage matrices, as it has no taste or smell, and does not affect mouthfeel.”